Fortrea Holdings (FTRE) Profit After Tax (2022 - 2026)
Fortrea Holdings (FTRE) reported Profit After Tax of -$23.6 million for Q1 2026, up 95.81% on a YoY basis from -$12.1 million in Q1 2025, and up 27.38% quarter-over-quarter from -$32.5 million in Q4 2025.
Fortrea Holdings (FTRE) Profit After Tax (2022 - 2026) Analysis & Trends
Fortrea Holdings has reported Profit After Tax for 5 years, with the latest figure at -$23.6 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax rose 95.81% year-over-year to -$23.6 million; the trailing twelve-month figure through Mar 2026 stood at -$446.9 million (up 43.46% YoY), and the FY2025 full-year result was -$986.2 million, down 200.21% from the prior year.
- Profit After Tax for Q1 2026 stood at -$23.6 million, up from -$32.5 million in the prior quarter.
- The five-year high for Profit After Tax was $66.4 million in Q2 2022, with the low at -$562.9 million in Q1 2025.
- Historically, Profit After Tax has averaged -$75.4 million across 5 years, with a median of -$25.8 million in 2024.
- Annual changes were most pronounced in 2024 — Profit After Tax sank 908.0% — and 2026, when it jumped 95.81%.
- Fortrea Holdings' Profit After Tax stood at $26.7 million in 2022, then sank by 282.02% to -$48.6 million in 2023, then declined by 25.93% to -$61.2 million in 2024, then surged by 46.9% to -$32.5 million in 2025, then gained by 27.38% to -$23.6 million in 2026.
- The last three Profit After Tax figures came in at -$23.6 million (Q1 2026), -$32.5 million (Q4 2025), and -$15.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Fortrea Holdings | 1.43 Bn | 1.28 Bn | 123.60 Mn | -23.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.60 Mn |
| Dec 31, 2025 | -32.50 Mn |
| Sep 30, 2025 | -15.90 Mn |
| Jun 30, 2025 | -374.90 Mn |
| Mar 31, 2025 | -562.90 Mn |
| Dec 31, 2024 | -61.20 Mn |
| Sep 30, 2024 | -27.90 Mn |
| Jun 30, 2024 | -138.40 Mn |
| Mar 31, 2024 | -101.00 Mn |
| Dec 31, 2023 | -48.60 Mn |
| Sep 30, 2023 | -16.10 Mn |
| Jun 30, 2023 | 30.80 Mn |
| Mar 31, 2023 | 12.50 Mn |
| Dec 31, 2022 | 26.70 Mn |
| Sep 30, 2022 | 60.60 Mn |
| Jun 30, 2022 | 66.40 Mn |